Structure–activity relationships of non-imidazole H3 receptor ligands. Part 1
- 5 August 2002
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (15) , 2031-2034
- https://doi.org/10.1016/s0960-894x(02)00309-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Influence of imidazole replacement in different structural classes of histamine H3-receptor antagonistsEuropean Journal of Pharmaceutical Sciences, 2001
- Genomics Meets Histamine Receptors: New Subtypes, New ReceptorsMolecular Pharmacology, 2001
- Novel Histamine H3-Receptor Antagonists with Carbonyl-Substituted 4-(3-(Phenoxy)propyl)-1H-imidazole Structures like Ciproxifan and Related CompoundsJournal of Medicinal Chemistry, 2000
- Central histaminergic system and cognitionNeuroscience & Biobehavioral Reviews, 2000
- Cloning and Functional Expression of the Human Histamine H3ReceptorMolecular Pharmacology, 1999
- Design, Synthesis, and Structure−Activity Relationships of Acetylene-Based Histamine H3 Receptor AntagonistsJournal of Medicinal Chemistry, 1999
- Therapeutic potential of histamine H3 receptor agonists and antagonistsTrends in Pharmacological Sciences, 1998
- Expression cloning of a cDNA encoding the bovine histamine H1 receptor.Proceedings of the National Academy of Sciences, 1991
- Molecular cloning of a gene encoding the histamine H2 receptor.Proceedings of the National Academy of Sciences, 1991
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptorNature, 1983